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DObjective: The purpose of this study was to review the long-term outcome of patients with Ebstein anomaly who
underwent complete repair as neonates and young infants.
Methods:BetweenMarch 1994 andMay 2010, 32 patients (23 neonates and 9 young infants) underwent surgery
for Ebstein anomaly. Mean weight was 3.9  2.0 kg (range, 1.9–8.6 kg). The Great Ormond Street Echocardi-
ography score was greater than 1.5 in 22 of the 23 neonates and greater than 1.0 in all infants. All associated
cardiac defects were repaired including pulmonary atresia in 15 and ventricular septal defect in 4. Primary out-
come measures included (1) early and late survival, (2) freedom from reoperation, (3) durability of tricuspid
valve repair, and (4) functional status.
Results: Early survival was 78.1% (25/32). There was 1 late death. Fifteen-year survival estimate was 74% 
8%. For patients with pulmonary atresia, early and late survival was 60% 12% (9/15) versus 94.1% (16/17)
(P<.05), respectively; for thosewithout pulmonary atresia, early and late survival was 60% 12% versus 85%
 10 (P¼ .06), respectively. The mean follow-up was 5.9 4.5 years (0.1–16 years). A biventricular repair was
achieved in 90.6% (29/32) patients. Median preoperative tricuspid regurgitation was 4/4 and at late follow-up, 1/
4. Freedom from reoperation at 15 years was 74%  10% for patients undergoing biventricular repair. All sur-
vivors are in New York Heart Association class I or II.
Conclusions: Biventricular repair of Ebstein anomaly in symptomatic neonates is feasible with good early and
late survival, especially in those without pulmonary atresia. Tricuspid valve repair is durable, and functional sta-
tus is excellent. (J Thorac Cardiovasc Surg 2011;141:1163-9)Earn CME credits at
http://cme.ctsnetjournals.org
Ebstein anomaly (EA) is a rare congenital heart defect that re-
sults from varying degrees of failure of delamination of the
tricuspid valve (TV) leaflets from the endocardium of the
right ventricle (RV).1 This results in apical displacement, par-
ticularly of the septal and posterior leaflets of the TV. The an-
terior leaflet is typically broad and sail-like and is based at the
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The Journal of Thoracic and Cartional portion as a result of atrialization.2 Age at presentation
can vary from neonate to adulthood.3,4 Symptoms in the
neonate result from a combination of TV regurgitation, RV
dysfunction, inadequate left ventricular filling owing to
ventricular septal bowing, inadequate pulmonary blood
flow, and arrhythmias. Mortality rates for symptomatic
neonates with EA are extraordinarily high.6 Neonates with
GreatOrmondStreet Echocardiogram (GOSE) scores greater
than 1.5, or greater than 1.1 with associated cyanosis, have
a mortality approaching 100%.4,6 In addition, neonates
with severe cardiomegaly with a cardiothoracic ratio
greater than 0.8, those with severe TV regurgitation, and
acyanotic neonates with a GOSE score greater than 1.0
associated with functional pulmonary atresia (PA) and
a large atrial septal defect (ASD) also have a dismal
prognosis.3,6,8 Surgical approaches for the management of
these critically ill neonates have varied across institutions
and include the Starnes RV exclusion procedure, systemic–
pulmonary shunts, hybrid-type procedures, and heart trans-
plantation.9-16 Single-ventricle palliation, first reported by
Starnes and associates9 in 1991, provided surgeons with the
first reproducible surgical procedure for symptomatic neo-
nates with EA and found wide acceptance in the pediatric
caregiver community. In 2000, Knott-Craig and associates12
published the first series of biventricular repairs (BVRs) indiovascular Surgery c Volume 141, Number 5 1163
TABLE 1. Comorbidities and associated cardiac defects
Single or multiple VSD 4
Anatomic PA 15
Functional PA 7
Mechanical ventilation 20
Hepatorenal failure 5
Diffuse coagulopathy 2
Intracranial hemorrhage grade III or IV 3
Hypoplastic branch pulmonary arteries 2
Small LV 3
Malignant tachyarrhythmias 4
VSD, Ventricular septal defect; PA, pulmonary atresia; LV, left ventricle.
Abbreviations and Acronyms
ASD ¼ atrial septal defect
BVR ¼ biventricular repair
EA ¼ Ebstein anomaly
GOSE ¼ Great Ormond Street Echocardiogram
PA ¼ pulmonary atresia
PS ¼ pulmonary stenosis
RV ¼ right ventricle
RVOT ¼ right ventricular outflow tract
TV ¼ tricuspid valve
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Dneonates with a 12%mortality in 8 patients followed up for 5
years. We12,14,17 have subsequently reported our surgical
technique, perioperative management strategy, and early
results illustrating the feasibility of performing a BVR in
critically ill neonates and infants with EA.
The purpose of this study was to examine the long-term
results in these patients who have undergone BVR as the
primary definitive operation either during the neonatal
period or early infancy.
PATIENTS AND METHODS
Study Design
Between March 1994 and May 2010, 44 consecutive symptomatic neo-
nates with EAwere referred to the senior authors (C.K.C., n ¼ 43; U.S.B.,
n ¼ 1) for surgical evaluation. These patients were managed at Children’s
Hospital of Oklahoma, Oklahoma City, Oklahoma (1994–2006), Univer-
sity of Alabama at Birmingham, Birmingham, Alabama (2006–2008),
and Le Bonheur Children’s Hospital, Memphis, Tennessee (2008–2010).
Of these 44 neonates, 2 died immediately after delivery despite perinatal
resuscitative efforts. Another 19 neonates could be successfully managed ini-
tially without surgery by a combination of prostaglandins, nitric oxide, inter-
mittent positive-pressure ventilation, and inotropic support as previously
described.12,13 Although these patients were ultimately discharged from the
hospital, 9 required surgical intervention during early infancy. The
remaining 23 critically ill neonates with EA required urgent surgical
intervention during the neonatal period. These 23 neonates and the 9 young
infants who were initially discharged comprise the study cohort (n ¼ 32).
A diagnosis of EAwas made by echocardiography using standard crite-
ria.1-3 Displacement of the septal leaflet was greater than 8 mm/m2 in most
cases as assessed by echocardiography. In 3 patients the posterior leaflet
was predominantly displaced rather than the usual septal leaflet. TV
regurgitation was assessed quantitatively by color Doppler using a scale
of 0 (none) to 4 (severe). The GOSE score4,6,14 was calculated as the
sum of the combined area of the right atrium and atrialized RV, divided
by the area of the sum of the functional RV and the left atrium and left
ventricle. Additional cardiac defects were assessed by echocardiography.
Patients with atrioventricular discordance associated with EA were not
included in the study group.
Primary outcomemeasures included (1) early and late survival, (2) free-
dom from reoperation, (3) durability of TV repair, (4) functional status
(New York Heart Association class), and (5) need for long-term antiar-
rhythmic medication.
Study Group (n ¼ 32)
Thirty-two patients with EA underwent surgical intervention during the
study period. There were 23 neonates and 9 infants. Seventeen were male1164 The Journal of Thoracic and Cardiovascular Sur(17/32; 53%). Median age at the time of the operation was 15 days. Mean
weight was 3.9  2.0 kg. The smallest neonate weighed 1.9 kg at a gesta-
tional age of 34 weeks with associated anatomic PA. Mean cardiothoracic
ratio was 0.92  0.02. The GOSE score was greater than 1.5 (4/4) in 22 of
23 neonates and greater than 1.0 (3–4/4) in all infants. Thirteen neonates
and 2 infants had associated anatomic PA. In addition, there was one
5-week-old infant with high-grade pulmonary stenosis (PS).
Complete BVR consisted of the following 5 aspects: (1) The technique
of TV repair evolved during the course of the study period, as experience
was gained and prior errors were recognized and modified. Initially, a Dan-
ielson-type repair11 was used when the anterior leaflet was well developed
and mobile. Later, the TV repair was effected at the level of the coapting
leaflets of the TV rather than at the true annulus. Finally, a Sebening-
type suture18 was added to fix the major papillary muscles of the anterior
leaflet to the interventricular septum to minimize the effects of pulmonary
hypertension in the early postoperative period. Often the TV leaflets were
underdeveloped, curtained, or dysplastic, making each repair somewhat
unique. (2) Reduction right atrioplasty was done to allow for lung expan-
sion and more efficient cardiac function. (3) The obligatory ASD was par-
tially closed, leaving a 3-mm fenestration to allow for right-to-left shunting
in the presence of postoperative RV dysfunction. (4) An adequate RVout-
flow tract (RVOT) was constructed for patients with anatomic PA or PS.
Different techniques were used for this: Initially, small transannular
patches using untreated autologous pericardium were used to create an
RVOT of about 7 mm in diameter. Later in our experience, aortic homo-
grafts were used more liberally. (5) All concomitant cardiac defects were
repaired at the time of the operation (Table 1).Preoperative Management and Surgical Indications
These critically ill patients were all initially managed in the intensive
care unit. Our perioperative strategy for these neonates has previously
been reported.12-14 Adequate sedation and paralysis were initially
provided to lower pulmonary vascular resistance and mean airway
pressures. Inotropic support in the form of dopamine or isoproterenol
was initiated to improve cardiac output. Prostaglandin infusion was
necessary for patients with anatomic PA or PS or those with elevated
pulmonary vascular resistance. Inhaled nitric oxide was also used to
reduce pulmonary vascular resistance. Daily echocardiograms were used
to assess the development of prograde pulmonary blood flow.
Indications for early surgical intervention included persistent ventilator
dependency, right heart failure unresponsive to medical therapy, severe
TV regurgitation associated with cyanosis, persistent need for significant
intravenous inotropic support, and persistent prostaglandin- dependent
circulation.Surgical Repair
Twenty-nine patients had a complete BVR (29/32, 90.6%) during the
neonatal period or infancy. Details of the repairs have been previouslygery c May 2011
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Dpublished.12,14,17 Salient features of the repairs are indicated under
subheadings of TV repair and management of the RVOT in PA.
TV repair. TV repair was done in 26 patients. TV repair was unneces-
sary in 1 patient because only mild tricuspid regurgitation was present, and
2 patients required initial TV replacement. One neonate was transferred
moribund after a failed Starnes RV exclusion procedure. At operation,
the patch from the exclusion procedure was taken down, and the heart
was fully septated. The TV was replaced with a mechanical prosthesis
and the RVOT reconstructed with an aortic homograft. Eight months later
the partly thrombosed mechanical prosthesis was replaced with a biopros-
thesis and a bidirectional Glenn anastomosis added to improve the longev-
ity of the bioprsthesis. This patient is currently asymptomatic 10 years later.
The second neonate was transferred from an outside facility after under-
going TV repair followed by TV replacement, which was complicated by
complete heart block. Before his transfer, he also underwent device closure
of a large ASD for hypoxemia and balloon fracture of the tricuspid biopros-
thesis secondary to prosthetic valve obstruction. At operation, the ASD de-
vice was removed and the atrial septum closed, and the malfunctioning TV
prosthesis was replaced with a functioning bioprosthesis. This patient is
currently asymptomatic 8 years later.
The surgical techniques for TV repair have previously been fully re-
ported.13,14,17 A Danielson-type repair was done in 10 patients, a DeVega
posterior annuloplasty in 10, anterior leaflet extension in 1, and a combina-
tion of annuloplasty and closure of leaflet fenestrations in 5 patients. A Seb-
ening stitch was added to the TV repair in 5 of the last 7 patients.18,19
Three patients did not have BVR: (1) An infant with associated ana-
tomic PA and badly scarred hypoplastic pulmonary arteries was transferred
to our facility after 4 prior sternotomies for systemic–pulmonary shunts
and revisions. At operation, the pulmonary arteries were augmented from
hilum to hilum using pulmonary homograft patches, and a bidirectional
Glenn shunt was placed. The associated PAwas not addressed. This patient
is currently being evaluated for 1½-ventricle repair. (2) A neonate with an-
atomic PA, diminutive functional RV, and rudimentary TV leaflets not ame-
nable to repair was palliated with a Starnes RV exclusion procedure. This
patient has subsequently undergone a successful bidirectional Glenn and
completion Fontan operation. (3) A neonate with anatomic PA and mild tri-
cuspid regurgitation underwent a systemic–pulmonary shunt only and has
subsequently undergone bidirectional Glenn anastomosis. The functional
RVwas diminutive and unsuitable for BVR. This patient is currently await-
ing Fontan completion.
All concomitant cardiac defects were repaired in patients having BVR
(Table 1). This included closure of single or multiple VSDs in 4 patients.
Management of RVOT. Fifteen patients had anatomic PA. High-
grade PS was present in 1 additional patient. Functional PA was present
at the time of surgery in another 7 patients.
Early in our experience, anatomic PAwas repaired with a transannular
patch (n¼ 8) or open pulmonary valvotomy (n¼ 1). Two of these patients
required postoperative support with extracorporeal membrane oxygena-
tion; they were later taken back to the operating room and the transannular
patch was replaced with a homograft. Because the hemodynamics were so
much better after placement of the homograft in the RVOT, even though
both these patients later died during the postoperative period, we subse-
quently elected to repair anatomic PAwith a small homograft in 3 further
patients, all of whom have survived.
Two patients who underwent BVR required a systemic–pulmonary
shunt for additional pulmonary blood flow. The need for a systemic–pulmo-
nary shunt was due to diminutive pulmonary arteries in 1 patient and a very
small functional RV in the other. Both were placed after weaning from car-
diopulmonary bypass, and hypoxemia was evident.
A bidirectional Glenn procedure was done in 5 patients who underwent
BVR. This was added to 4 of 9 infant repairs (all>3 months old at time of
repair) and added to a neonatal repair at 7 months of age secondary to re-
sidual moderate tricuspid regurgitations. In 1 of the patients the bidirec-
tional Glenn shunt was taken down during the perioperative periodThe Journal of Thoracic and Carbecause of systemic venous hypertension. A bidirectional Glenn procedure
was also the second-stage palliation in the 3 patients stratified to a single-
ventricle pathway.
Follow-up
Medical records were reviewed to obtain clinical, surgical, and perio-
perative data. Long-term follow-up data were obtained via clinic visits,
telephone interviews, echocardiography, and catheterization data, and
follow-up was done with full approval by the institutional review board.
Follow-up extends up to 16 years and is complete in 93% of patients.
The mean follow-up was 5.9  4.5 years.
Statistical Method
The data are presented as mean  standard deviation for the normally
distributed variables and median with interquartile range for the non–nor-
mally distributed variables. Normally distributed continuous variables
(paired) were compared by the paired t test, and non–normally distributed
variables were compared by the Wilcoxon test. Categorical variables were
compared by Fisher’s exact test owing to small counts. We tested whether
the presence of PA or the need for extracorporeal membrane oxygenation
were predictors of mortality. The Kaplan–Meier cumulative survival and
need for reoperation estimates were assessed for all patients with EA
treated with BVR. The Kaplan–Meier percentiles are expressed as mean
 standard error. The data were analyzed with R 2.10.1 software, package
‘‘survival,’’ and all the results were validated with SPSS 17 (SPSS, Inc,
Chicago, Ill).
RESULTS
Early Survival
Early survival was 78.1% (25/32). For patients with and
without PA, early survival was 60% (9/15) versus 94.1%
(16/17) (P ¼ .05). For patients undergoing BVR (n ¼ 29),
early survival was 76%  10%. Early survival among ne-
onates needing surgery was 69.5% (16/23).
There were no early survivors among the neonates
(n ¼ 3) who needed extracorporeal membrane oxygenation
postoperatively (P ¼ .01). All of these neonates had ana-
tomic PA, and the mode of death was cardiac failure with
RV distention in 2 and persistent bleeding in 1. Two of
them were taken back to surgery and the transannular patch
replaced with an aortic homograft. Although the hemody-
namics were much improved postoperatively, 1 patient
had a grade IV intracranial hemorrhage and care was with-
drawn, and the other died of persistent coagulopathy.
All neonates with grade 3-4 intracranial hemorrhage be-
fore initial repair (n ¼ 3) died, and those in whom high-
grade intracranial hemorrhage developed postoperatively
(n ¼ 2) also died (P ¼ .01).
The 3 patients who were stratified to a single-ventricle
pathway all survived initial palliation and are well at late
follow-up after having undergone a bidirectional Glenn
procedure.
Late Survival
There has been 1 late death. The 15-year survival esti-
mate for the entire study group (n ¼ 32) was 74%  8%
(Figure 1). The single late death resulted from respiratorydiovascular Surgery c Volume 141, Number 5 1165
FIGURE 1. Kaplan–Meier survival estimate for all patients with Ebstein
anomaly (n ¼ 32). FIGURE 3. Comparison of survival for neonates undergoing biventricular
repair with (n¼ 11) and without (n¼ 10) anatomic pulmonary atresia (PA)
(P ¼ .03).
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Dsyncytial viral pneumonia 2 years later in a patient with
known bronchopulmonary dysplasia as a preterm infant.
For the patients having a BVR (n ¼ 29), 15-year survival
was 72%  9% (Figure 2). For patients with and without
PA, 15-year survival was 60%  12% and 85%  10%
(P ¼ .06). In the subgroup of neonates with and without
PA, the 15-year survival estimate was 40%  15% versus
79%  13% (P ¼ .03) (Figure 3).FIGURE 2. Survival after biventricular repair for Ebstein anomaly
(n ¼ 29).
1166 The Journal of Thoracic and Cardiovascular SurTV Function and Durability
The TV z-score preoperatively was 3.1 1.6. In patients
undergoing TV repair, the mean reduction in TV annulus
was 10.4  5.2 mm. Median severity of TV regurgitation
preoperatively was 4/4 and at late follow-up, 1/4. This
was a highly significant improvement (P ¼ .01)FIGURE 4. Severity of tricuspid valve regurgitation before repair and at
late follow-up. Severity grades: 0 ¼ none, 1 ¼ mild, 2 ¼ mild plus,
3 ¼ moderate, and 4 ¼ severe.
gery c May 2011
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D(Figure 4). Progressive TV stenosis has not been evident in
the follow-up period for patients undergoing BVR.
Freedom From Reoperation
The patients having a palliative procedure (n ¼ 3) have
all undergone obligatory reoperation. Four patients who
had undergone a BVR have required reoperation on the
TV. In 2 patients, reoperation represented re-replacing
a valve prosthesis that had been placed during the initial op-
eration, and 2 additional patients required TV replacement
for significant tricuspid regurgitation. In 2 patients a bidirec-
tional Glenn procedurewas added at the time of TV replace-
ment. The Kaplan–Meier estimate of freedom from
reoperation was 74%  10% at 15 years for patients who
underwent BVR (n ¼ 29) (Figure 5).
Arrhythmias and Functional Status
Although 4 neonates had malignant tachyarrhythmias be-
fore neonatal BVR, only 1 patient is taking prophylactic an-
tiarrhythmic medication at the discretion of his cardiologist.
All survivors are in New York Heart Association class I or
II. The first neonate in the series currently plays football on
his high school team as a wide receiver. His most recent
echocardiogram indicates normal biventricular function
with trivial TV regurgitation.
DISCUSSION
EA is a particularly difficult congenital heart lesion to
manage in the severely symptomatic neonate. Early survival
has historically remained dismal despite various surgical
and nonsurgical options.3,4,6 Even when EA is diagnosedFIGURE 5. Freedom from reoperation for patients having biventricular
repair (n ¼ 29).
The Journal of Thoracic and Carin infancy beyond the first month of life, the mortality
risk is 8 times higher than in patients receiving the
diagnosis after 1 year of age.3 Recent data from the Pediat-
ric Health Information System database have shown that
even less symptomatic neonates who were treated medi-
cally in institutions in the United States between 2002 and
2006 had an early mortality of 22%.20 This underscores
the tenuous and unpredictable course of the disease in neo-
nates, as opposed to older infants and children.5,7,11
In this series of symptomatic neonates referred for surgi-
cal intervention, 45% were initially managed nonsurgi-
cally. However, 47% of these required surgery during
early infancy. These data support the observation that about
50% of acyanotic symptomatic neonates with EA will die
within the first year of life without surgical intervention.6
For this subset of patients (n ¼ 9), which represents one
of the largest reported series of young infants undergoing
surgery for EA, our early and late survival was 100%.
This is significantly better than the 50% early survival re-
cently reported by the European Congenital Heart Surgeons
multicenter trial for infants with EA having surgery
between 2002 and 2005.21
In our experience with severely symptomatic neonates
who remained critically ill and required surgery during the
neonatal period (n ¼ 23), we were able to achieve a BVR
in 86%. This is in contrast to the experience of both Reemt-
sen16 and Shinkawa,22 who reported that they were able to
achieve a BVR in only about 10% of their patients. The ex-
planation for these differences in surgical approach may re-
late tomorphologically different populations or institutional
bias. Needless to say, in this subset of critically ill neonates
with EA, the predicted early mortality without surgery
approximates 100%.4,6 Our strategy of selective BVR
resulted in a very encouraging early survival of 78.1%
overall and 69.5% for the neonates. For the neonates
without anatomic PA, early survival was 90%, whereas
those neonates with associated PA had an early survival of
53.8%. If one analyzes only those neonates with anatomic
PA who had BVR, early survival was only 45.5%. This is
similar to the experience of Bove’s group (Shinkawa and
associates22) who had a 25% early survival in a similar sub-
set of neonates.
Although neonates with EA and anatomic PA clearly still
represent the Achilles heel in critically ill neonates with EA,
certain observations have been made that have altered our
management strategy during the latter years of the study pe-
riod: (1) The degree of tricuspid regurgitation seems in-
versely proportional to the diastolic dimension of the
functional RV. When tricuspid regurgitation therefore is
mild (1–2/4), we now advocate ligating the ductus, con-
structing a systemic–pulmonary shunt, and, if feasible, do-
ing a very conservative open pulmonary valvotomy. All this
is done without placing the patient on bypass. At 4 months
of age, a bidirectional Glenn anastomosis is performed, anddiovascular Surgery c Volume 141, Number 5 1167
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Dif the RV has developed, the ASD is partially closed and the
RVOT is reconstructed with either a transannular patch or
a homograft. (2) If significant tricuspid regurgitation is
present, generally the functional RV is much larger but
the attachments of the TV leaflet may be very close to the
atretic RVOT. If this is the case, replacing the RVOT with
a homograft may further compromise the integrity of the
TV.Wewould therefore advocate a Starnes procedure using
a fenestrated patch. (3) On the other hand, if the functional
RV is reasonable in size and the TVamenable to repair (as is
often the case), wewould reconstruct the RVOTwith a small
(7–9mm) aortic homograft, then repair the TV, and partially
close the ASD as previously described.
In 2 neonates with anatomic PAwho underwent transan-
nular patch and required extracorporeal membrane oxygen-
ator support postoperatively, reoperation was performed for
RV–pulmonary artery conduit placement using a small ho-
mograft. In both cases, the patients were hemodynamically
improved and would certainly have survived except for sub-
sequent comorbidities. Therefore, using this current man-
agement algorithm, we have now managed 4 consecutiveFIGURE 6. Surgical algorithm for symptomatic neonates with Ebstein anoma
pulmonary artery; SP, systemic–pulmonary.
1168 The Journal of Thoracic and Cardiovascular Surneonates with EA and PA over the past 2 years without early
or late mortality. Our current algorithm for surgical man-
agement is illustrated in Figure 6.
Another difference in our current management strategy
concerns those patients with wide open pulmonary regurgi-
tation and tricuspid regurgitation with cardiogenic shock;
today we would take this patient directly to the operating
room to ligate the patent ductus arteriosus, place a small pe-
ripheral Blalock–Taussig shunt, and incompletely ligate the
main pulmonary artery without the aid of cardiopulmonary
bypass. The patient would be taken for reoperation 3 to 7
days later once the pulmonary vascular resistance had
been lowered and the anatomy and morphology more fully
evaluated.
Our early and late survivals compare favorably with those
of other recent studies.3,6 In a multicenter study from the
European Congenital Heart Surgeons Association database,
the operative mortality for any surgical intervention during
the neonatal period was 53.8%.20 In a nonconsecutive
follow-up series of 16 patients, Reemtsen and associates16 re-
ported an early mortality of 24% for neonates with EAwholy. TR, Tricuspid regurgitation; PDA, patent ductus arteriosus; MPA, main
gery c May 2011
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Dunderwent single-ventricle palliation. Recently, Shinakawa
and colleagues22 reviewed their experience with surgical
management of 24 neonates with EA. Their survival esti-
mates for patients treated with the Starnes RVexclusion pro-
cedure single-ventricle palliation was 63% at 10 years. In
contrast, the 10-year survival was 76% for those patients in
whom placing a systemic–pulmonary shunt was sufficient
to allow them to survive early infancy.
We have shown that TV repair for neonatal EA is durable
with 74% long-term freedom from reoperation. In themajor-
ity of patients, the degree of TV regurgitation has remained
stable and mild over the follow-up period. Generally, the
patients have excellent functional status as exemplified by
the first patient who currently is a track-and-field athlete
and a running back on the high school football team 16 years
after neonatal BVR. More comprehensive exercise testing is
necessary to determine whether the functional status is re-
flective of a favorable maximum volume of oxygen use.
From the echocardiograms done at late follow-up, it seems
as though the TV repair has not resulted in progressive TV
stenosis, and no patient has needed reintervention for TV
stenosis in our experience.
The low incidence of arrhythmias during the follow-up
period remains an interesting observation. We have previ-
ously speculated that arrhythmias in patients with EA
may be partly related to chronic right-sided volume over-
load and that early repair with correction of this hemody-
namic impropriety may result in less than expected
arrhythmias. This needs further evaluation but remains an
encouraging aspect of early repair.
Neonatal EA continues to be a challenging surgical prob-
lem. BVR for neonatal EA provides good long-term sur-
vival and freedom from reoperation, particularly in those
patients in whom a competent TV repair is achieved.
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